Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (1)
  • 2024 (1)
  • 2023 (12)
  • 2022 (11)
  • 2021 (8)
  • 2020 (4)
  • 2019 (3)

Subject

  • Drug Trafficking (662)
  • Synthetic drugs (215)
  • Guns/Weapons (187)
  • Guilty Plea (172)
  • Arrests/Convictions - Major (58)
  • Overdose (58)
  • Prescription Drugs (50)
  • Diversion Division (41)
  • Gangs (35)
  • Fake Pills (25)
  • Major Law Enforcement Operation (21)
  • Money Laundering (19)
  • Seizures (Drugs/Property) (19)
  • OCDETF/Task Force (18)
  • Take Back Day (16)
  • Task Forces/Task Force Officers (15)
  • Asset Forfeiture (9)
  • HIDTA (8)
  • Extraditions (7)
  • Fentanyl Awareness (7)
  • Terrorism (6)
  • Outreach/Drug Prevention (5)
  • Dark Web- Internet Trafficking (3)
  • International/Foreign Operations (3)
  • One Pill Can Kill (3)
  • Press Conferences (3)
  • Prevention/Education - DEA websites GSAD, JTT etc (3)
  • Public and Media Affairs - also see Congressional Affairs (3)
  • Other (2)
  • El Paso Intelligence Center (1)
  • Narcoterrorism (1)
  • Red Ribbon (1)
  • Pharmaceuticals/Pharmacists/Physicians (40)

Drug Name

  • Oxycodone (10)
  • Fentanyl (5)
  • Cocaine (1)
  • Ketamine (1)

Field Division

  • Washington, DC (35)
  • St. Louis (32)
  • Miami (16)
  • Atlanta (12)
  • New Jersey (11)
  • El Paso (9)
  • Sede (9)
  • Dallas (8)
  • Houston (7)
  • San Francisco (7)
  • Seattle (7)
  • Louisville (5)
  • New England (5)
  • San Diego (5)
  • Los Angeles (4)
  • New Orleans (4)
  • Rocky Mountain (3)
  • Omaha (2)
  • Phoenix (2)
  • Philadelphia (1)
  • New York (21)
  • Chicago (19)
Clear All Results
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

Noviembre 19, 2025
NEW YORK – United States Drug Enforcement Administration (“DEA”) New York Division Special Agent in Charge Frank Tarentino, DEA San Francisco Division Special Agent in Charge Robert Beris, along with our law enforcement partners Homeland Security Investigations (“HSI”) New York , U.S. Department of Health and Human Services – Office...
Noviembre 19, 2025
PRESS RELEASE

Psychiatrist Sentenced to 48 Months for Unlawful Distribution of Controlled Substances

Marzo 05, 2024
Milwaukee, Wis. - John McGarry, Assistant Special Agent in Charge of U.S. Drug Enforcement Administration-Milwaukee and U.S. Attorney Gregory J. Haanstad, for the Eastern District of Wisconsin that on March 4, 2024, John D. Whelan (age: 77), a psychiatrist, was sentenced to a term of 48 months’ imprisonment followed by...
Marzo 05, 2024
PRESS RELEASE

Two Suburban Chicago Physicians Sentenced to Federal Prison for Health Care Fraud

Diciembre 20, 2023
CHICAGO — Shiela Lyons, Special Agent in Charge of U.S. Drug Enforcement Administration-Chicago Field Division, and Acting U.S. Attorney Morris Pasqual for the Northern District of Illinois announced that two suburban Chicago physicians have been sentenced to federal prison for prescribing opioids to individuals who lacked a legitimate medical need...
Diciembre 20, 2023
PRESS RELEASE

Fort Salonga Urologist and Wife Charged with Criminal Sale of a Prescription for a Controlled Substance and Falsifying Business Records

Diciembre 14, 2023
SUFFOLK COUNTY, N.Y. – Suffolk County District Attorney Raymond A. Tierney and Drug Enforcement Administration Special Agent in Charge Frank A. Tarentino III today announced the indictment of Francis and Jessica Martinis, of Fort Salonga, accused of Criminal Sale of Prescription for a Controlled Substance by a Practitioner and Falsifying...
Diciembre 14, 2023
PRESS RELEASE

Queens Pharmacist Sentenced to 60 Months in Prison for Illegally Distributing Oxycodone and Filing False Tax Returns

Noviembre 29, 2023
BROOKLYN, N.Y. - Today, Daniel E. Russo was sentenced to 60 months in prison by United States District Judge Dora L. Irizarry for conspiracy to distribute and possess with intent to distribute oxycodone, distribution and possession of oxycodone, and nine counts of filing false personal and corporate tax returns. In...
Noviembre 29, 2023
PRESS RELEASE

Nurse Practitioner Arrested, Charged with Selling Oxymorphone

Octubre 05, 2023
BUFFALO, N.Y. - U.S. Attorney Trini E. Ross announced today that Michael Ostolski, 55, of North Tonawanda, NY, was arrested and charged by criminal complaint with conspiracy to distribute oxymorphone. The charge carries a maximum penalty of 20 years in prison and a $1,000,000 fine. Assistant U.S. Attorney Michael J...
Octubre 05, 2023
PRESS RELEASE

Illinois Man Sentenced to 30 Months for Theft of Medical Products and Possession of a Controlled Substance with Intent to Distribute

Septiembre 13, 2023
SPRINGFIELD, Ill. – Todd C. Smith, Assistant Special Agent in Charge at U.S. Drug Enforcement Administration Chicago Field Division, and U.S. Attorney Gregory K. Harris for the Central District of Illinois announced that Issac Jackson, 29, of Le Roy, Illinois, was sentenced on Sept. 7, 2023, to 30 months in...
Septiembre 13, 2023
PRESS RELEASE

Physician Assistant at Chicago Medical Practice Charged with Fraudulently Writing Opioid Prescriptions

Agosto 04, 2023
CHICAGO — Sheila G. Lyons, Special Agent in Charge of U.S. Drug Enforcement Administration Chicago Field Division, and Acting U.S. Attorney Morris Pasqual for the Northern District of Illinois announced that a physician assistant who formerly worked at a Chicago medical practice has been charged in federal court with fraudulently...
Agosto 04, 2023
PRESS RELEASE

Suburban Chicago Physician Sentenced to Federal Prison for Prescribing Opioids Without a Medical Exam

Julio 17, 2023
CHICAGO — Sheila G. Lyons, Special Agent in Charge of U.S. Drug Enforcement Administration Chicago Field Division, and Acting U.S. Attorney Morris Pasqual for the Northern District of Illinois announced that a suburban Chicago physician has been sentenced to a federal prison term for prescribing opioids to patients without a...
Julio 17, 2023
PRESS RELEASE

Catskill Pharmacy Pays $65,000 to Resolve Controlled Substances Act Allegations

Junio 22, 2023
ALBANY, NEW YORK – Greene Pharma LLC, dba Greene Medical Arts Pharmacy (Greene Pharma), a pharmacy in Catskill, New York, agreed to pay $65,000 to resolve allegations that it failed to comply with the Controlled Substances Act (CSA). United States Attorney Carla B. Freedman and Special Agent in Charge Frank...
Junio 22, 2023
Showing 1 - 10 of 40 results

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Página 4
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster